Deborah R. Surman

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling”.

Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0887

N/A

0DataRank · unranked

7 citations

Yue Xu, Min-Jung Lee, Jane B. Trepel, Kate Brown, Maheshwari Ramineni +8 more

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile

Frontiers in Oncology(2023)10.3389/fonc.2022.1094210

N/A

0DataRank · unranked

5 citations

Lisa M. Jenkins, Daniel R. Crooks, Deborah R. Surman, Sharlyn J. Mazur, Yuan Xu +9 more

Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0873

N/A

0DataRank · unranked

3 citations

Cristian G. Medina, Deborah R. Surman, Lacey E. Dobrolecki, Monica Vilchis, Maheshwari Ramineni +10 more